1
|
Croce CM: Oncogenes and cancer. N Engl J
Med. 358:502–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chandra D: Mitochondria as Targets for
Phytochemicals in Cancer Prevention and Therapy. Springer; New
York, USA: pp. 62–64. 2013
|
3
|
Cooper GM: The Cell: A Molecular Approach.
2nd. Sinauer Associates; Sunderland, MA: 2000
|
4
|
Andrade FH, Figueiroa FC, Bersano PR,
Bissacot DZ and Rocha NS: Malignant mammary tumor in female dogs:
Environmental contaminants. Diagn Pathol. 5:452010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Casey SC, Amedei A, Aquilano K, Azmi AS,
Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR,
et al: Cancer prevention and therapy through the modulation of the
tumor microenvironment. Semin Cancer Biol. 35:S199–S223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Seifu D, Assefa F and Abay SM: Medical
plants as antioxidant agents: Understanding their mechanism of
action and therapeutic efficacy. Research Signpost; Kerala, India:
pp. 97–145. 2012
|
7
|
Efferth T, Miyachi H and Bartsch H:
Pharmacogenomics of a traditional Japanese herbal medicine (Kampo)
for cancer therapy. Cancer Genomics Proteomics. 4:81–91.
2007.PubMed/NCBI
|
8
|
Hsu S, Yu FX, Huang Q, Lewis J, Singh B,
Dickinson D, Borke J, Sharawy M, Wataha J, Yamamoto T, et al: A
mechanism-based in vitro anticancer drug screening approach for
phenolic phytochemicals. Assay Drug Dev Technol. 1:611–618. 2003.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Siriwatanametanon N, Fiebich BL, Efferth
T, Prieto JM and Heinrich M: Traditionally used Thai medicinal
plants: In vitro anti-inflammatory, anticancer and antioxidant
activities. J Ethnopharmacol. 130:196–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Solowey E, Lichtenstein M, Sallon S,
Paavilainen H, Solowey E and Lorberboum-Galski H: Evaluating
medicinal plants for anticancer activity. ScientificWorldJournal.
2014:7214022014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Greenwell M and Rahman PK: Medicinal
Plants: Their Use in Anticancer Treatment. Int J Pharm Sci Res.
6:4103–4112. 2015.PubMed/NCBI
|
12
|
Gao S, Basu S, Yang G, Deb A and Hu M:
Oral bioavailability challenges of natural products used in cancer
chemoprevention. Pro Chem. 25:1553–1574. 2013.
|
13
|
Choi MS, Yuk DY, Oh JH, Jung HY, Han SB,
Moon DC and Hong JT: Berberine inhibits human neuroblastoma cell
growth through induction of p53-dependent apoptosis. Anticancer Res
28 (6A). 3777–3784. 2008.
|
14
|
King KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Foster I: Cancer: A cell cycle defect.
Radiography. 14:144–149. 2008. View Article : Google Scholar
|
16
|
Thatte U and Dahanukar S: Apoptosis:
Clinical relevance and pharmacological manipulation. Drugs.
54:511–532. 1997. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pearson M, Carbone R, Sebastiani C, Cioce
M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S,
Pandolfi PP, et al: PML regulates p53 acetylation and premature
senescence induced by oncogenic Ras. Nature. 406:207–210. 2000.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Vermeulen K, Berneman ZN and Van
Bockstaele DR: Cell cycle and apoptosis. Cell Prolif. 36:165–175.
2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang
HI, Wang CJ, Yang SF, Liou YS and Kuo WH: Berberine induces
apoptosis in SW620 human colonic carcinoma cells through generation
of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
Arch Toxicol. 81:719–728. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sun Y, Xun K, Wang Y and Chen X: A
systematic review of the anticancer properties of berberine, a
natural product from Chinese herbs. Anticancer Drugs. 20:757–769.
2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Serafim TL, Oliveira PJ, Sardao VA,
Perkins E, Parke D and Holy J: Different concentrations of
berberine result in distinct cellular localization patterns and
cell cycle effects in a melanoma cell line. Cancer Chemother
Pharmacol. 61:1007–1018. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bremer E, van Dam G, Kroesen BJ, de Leij L
and Helfrich W: Targeted induction of apoptosis for cancer therapy:
Current progress and prospects. Trends Mol Med. 12:382–393. 2006.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Yin X, Zhou J, Jie C, Xing D and Zhang Y:
Anticancer activity and mechanism of Scutellaria barbata extract on
human lung cancer cell line A549. Life Sci. 75:2233–2244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Krey AK and Hahn FE: Berberine: Complex
with DNA. Science. 166:755–757. 1969. View Article : Google Scholar : PubMed/NCBI
|
25
|
Meeran SM, Katiyar S and Katiyar SK:
Berberine-induced apoptosis in human prostate cancer cells is
initiated by reactive oxygen species generation. Toxicol Appl
Pharmacol. 229:33–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Letasiová S, Jantová S, Cipák L and
Múcková M: Berberine-antiproliferative activity in vitro and
induction of apoptosis/necrosis of the U937 and B16 cells. Cancer
Lett. 239:254–262. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jantova S, Cipak L and Letasiova S:
Berberine induces apoptosis through a mitochondrial/caspase pathway
in human promonocytic U937 cells. Toxicol In Vitro. 21:25–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Król M, Pawłowski KM, Szyszko K,
Maciejewski H, Dolka I, Manuali E, Jank M and Motyl T: The gene
expression profiles of canine mammary cancer cells grown with
carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro.
BMC Vet Res. 8:352012. View Article : Google Scholar : PubMed/NCBI
|